**Specifications table**TableSubject areaChemistry, BiologyMore specific subject areaPoint-of-care testingType of dataFigureHow data was acquiredThe epoc^®^ blood analysis system (Epocal Inc., Ottawa, Ontario, Canada)Data formatAnalyze dataExperimental factorsPatients under cardiopulmonary bypass were all heparinized as routineExperimental featuresLinearity was evaluated using 5 levels of Eurotrol epoc Calibration Verification Fluids and 5 levels of Eurotrol epoc Hematocrit Verification Fluids (Eurotrol B.V., Keplerlaan, The Netherlands) on 3 epoc^®^ blood analysis systems. Linearity materials were analyzed in triplicate on each system. Remnant specimens from cardiopulmonary bypass patients collected in plain 3 mL syringe for routine clinical analysis on GEM4000 in the cardiovascular operating room were used. After being analyzed on GEM4000 and all 3 epoc meters, samples were analyzed in Abbott iSTAT, Nova CCX analyzer, Roche Accu-Chek Inform II and Performa glucose meters side by side, with all measurements performed within 5 min.Data source locationSaint John, New Brunswick, CanadaData accessibilityData are within this article

**Value of the data**•Detailed analytical linearity analysis for 9 parameters on the epoc^®^ meters was presented.•Comparison study was conducted on 40 cardiopulmonary bypass patients.•The data helps medical laboratories and point-of-care testing users to make an informed decision on blood gas analyzer selection.

1. Data {#s0005}
=======

The data contains information on the analytical linearity performances for 9 parameters on 3 epoc^®^ meters ([Supplementary Fig. 1](#s0040){ref-type="sec"}). It also contains information on the cardiopulmonary bypass patient sample comparison study for analytical accuracy performance for 8 parameters on 3 epoc^®^ meters ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}).

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. The epoc^®^ blood analysis system {#s0015}
--------------------------------------

The epoc^®^ blood analysis system (Epocal Inc., Ottawa, Ontario, Canada) is a newly developed hand-held analyzer for testing whole blood samples at point-of-care, which provides blood gas, electrolytes, ionized calcium, glucose, lactate, and hematocrit/calculated hemoglobin in 30 seconds. This system contains a test card, a wireless card reader, and a host mobile computer. pH, pCO~2~, sodium, potassium, and ionized calcium are measure potentiometrically; pO~2~, glucose, and lactate are measured amperometrically, whereas hematocrit is determined conductometrically [@bib2]. Hemoglobin is calculated from the measured hematocrit using the formula: Hemoglobin (g/L)=Hematocrit (decimal fraction)×340 [@bib3], [@bib4].

2.2. Linearity study {#s0020}
--------------------

The epoc^®^ point-of-care blood analysis system was evaluated using several Clinical and Laboratory Standards Institute (CLSI) evaluation protocols for testing the linearity (EP6) [@bib5]. Five levels of Eurotrol epoc Calibration Verification Fluids (Eurotrol B.V., Keplerlaan, The Netherlands, lot\#183-B407), and 5 levels of Eurotrol epoc Hematocrit Verification Fluids (Eurotrol B.V., Keplerlaan, The Netherlands, lot\#190-B404) were measured on all three epoc^®^ blood analysis systems. These linearity materials were analyzed in triplicate on each system respectively.

2.3. Comparison study {#s0025}
---------------------

The epoc^®^ point-of-care blood analysis system was evaluated using several Clinical and Laboratory Standards Institute (CLSI) evaluation protocols for testing the accuracy (EP15) [@bib6] and bias (EP9) [@bib7]. Remnant specimens from 40 heparinized CPB patients collected in plain 3 mL syringe (Becton Dickinson, Franklin Lakes, New Jersey) for routine clinical analysis on GEM4000 (Instrumentation Laboratory, Bedford, MA, USA) in the cardiovascular operating room of the Saint John Regional Hospital, Horizon Health Network, were used for this study. Samples collected were of arterial, mixed venous, and venous types. After being analyzed on GEM4000 and all 3 epoc meters (therefore total epoc^®^ measurements were up to 118), samples were analyzed in Abbott iSTAT (Abbott Point of Care, Princeton, NJ, USA), Nova CCX analyzer (Nova Biomedical Corporation, Waltham, MA, USA), Accu-Chek Inform II and Performa glucose meters (Roche Diagnostics, Basel, Switzerland) side by side, with all measurements performed within 5 min. All testing devices were run according to manufacturers' instructions by a medical laboratory technologist. These arrangements attempted to eliminate pre-analytical errors associated with blood analysis, such as different sample collection containers and sensitive specimen stability [@bib8], [@bib9].

2.4. Statistical method {#s0030}
-----------------------

Statistical analysis was carried out using Microsoft Excel. The best fit line by linear regression was used to evaluate assay linearity ([Supplementary Fig. 1](#s0040){ref-type="sec"}). Regression analysis was used to evaluate method comparisons ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}). Bland--Altman analysis was constructed to assess systematic bias between methods (see Ref. [@bib1]). Comparison studies on hemoglobin measurements see [Fig. 1](#f0005){ref-type="fig"} in Ref. [@bib1].

Appendix A. Supplementary material {#s0040}
==================================
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Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2016.01.040](http://dx.doi.org/10.1016/j.dib.2016.01.040){#ir0005}.
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